Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/26/2010EP2189451A1 Benzamide derivatives, their preparation and uses in medicine thereof
05/26/2010EP2189449A1 Aminopyrazole amide derivative
05/26/2010EP2189448A1 Processes for the Separation of 3-Benzazepine Racemates
05/26/2010EP2189446A1 Novel 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy]-n'-(butoxycarbonyl)benzamidine crystals
05/26/2010EP2189445A1 Five-membered heterocyclic compound
05/26/2010EP2189443A1 Tricyclic amide compound
05/26/2010EP2189440A1 Tricyclic amine compound
05/26/2010EP2189439A2 CaSR antagonist
05/26/2010EP2189168A1 Implantable microbial cellulose materials for various medical applications
05/26/2010EP2189161A1 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
05/26/2010EP2189160A1 Composition comprising sesamin component and vitamin b1 component
05/26/2010EP2189159A1 Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
05/26/2010EP2189158A1 Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
05/26/2010EP2189157A1 EYE DROP COMPRISING DIBENZO[b,e]OXEPIN DERIVATIVE
05/26/2010EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition
05/26/2010EP2189155A1 Oral composition with an antiaging effect on the skin
05/26/2010EP2189154A1 Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
05/26/2010EP2188396A2 Gene silencing of the brother of the regulator of imprinted sites (boris)
05/26/2010EP2188301A2 Novel steroidal esters of 17-oximino-5-androsten-3 beta-ol
05/26/2010EP2188299A2 A method for treating diabetes
05/26/2010EP2188297A1 Pyrrolo ý2,1-c¨ý1, 4¨benzodiazepine-glycoside prodrugs useful as a selective anti tumor agent
05/26/2010EP2188296A1 Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods
05/26/2010EP2188293A1 6-substituted sulfonyl azabicycloý3.2.1¨octanes useful to inhibit 11 -hydroxysteroid dehydrogenase type-1
05/26/2010EP2188292A1 2- [ (2-{phenylamino}-1h-pyrrolo [2, 3-d]pyrimidin-4-yl) amino]benzamide derivatives as igf-1r inhibitors for the treatment of cancer
05/26/2010EP2188291A2 Fused bicyclic pyrimidines
05/26/2010EP2188290A1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents
05/26/2010EP2188289A2 (7h-pyrrolo[2,3-d]pyrimidin-4-yl)-piperazines as kinase inhibitors for the treatment of cancer and inflammation
05/26/2010EP2188288A1 Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
05/26/2010EP2188286A1 Process for the preparation of pyrido [2, 1-a]isoquinoline derivatives and polymorphic froms thereof
05/26/2010EP2188285A1 Pyrazoloquinoline and pyrazolonaphthyridine derivatives as gaba alpha ligands
05/26/2010EP2188284A2 Tricyclic heterocyclic compounds as gaba a modulators
05/26/2010EP2188283A1 Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
05/26/2010EP2188282A2 1,2-diamido-ethylene derivatives as orexin antagonists
05/26/2010EP2188281A1 Modulation of immune responses by administration of roxithromycin or its derivative
05/26/2010EP2188280A2 Imidazopyridinones
05/26/2010EP2188279A2 1,3 and 1,3,5 substituted imidazoles as antihypertensiva
05/26/2010EP2188278A1 Phthalazinone derivatives
05/26/2010EP2188277A1 Quinazolinedione chymase inhibitors
05/26/2010EP2188276A1 Substituted hydantoins
05/26/2010EP2188274A1 Viral polymerase inhibitors
05/26/2010EP2188272A2 Phenyl- and benzylthiazolylpiperazine derivatives for the treatment of neurodegenerative diseases
05/26/2010EP2188271A2 Heterocyclic compounds and uses as anticancer agents
05/26/2010EP2188268A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
05/26/2010EP2188267A2 Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer
05/26/2010EP2188263A1 Benzimidazole derivatives used as fxr agonists
05/26/2010EP2188262A1 Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain
05/26/2010EP2188261A1 Therapeutic compounds
05/26/2010EP2188260A1 Therapeutic quinoline and naphthalene derivatives
05/26/2010EP2188259A1 Method of making and administering quinoline derivatives as anti-cancer agents
05/26/2010EP2188258A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products
05/26/2010EP2188256A1 Renin inhibitors
05/26/2010EP2188255A1 Heterocyclic amides useful for the treatment of cancer and psoriasis
05/26/2010EP2188253A2 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
05/26/2010EP2188245A1 Nitric oxide releasing derivatives of paracetamol
05/26/2010EP2187957A2 Selective cytopheresis devices and related methods thereof
05/26/2010EP2187897A1 Composition for preventing virus infection comprising poly-gamma-glutamic acid
05/26/2010EP2187896A2 Micro-rnas that control myosin expression and myofiber identity
05/26/2010EP2187895A1 Composition containing microrna-21 inhibitor for enhancing radiation sensitivity
05/26/2010EP2187893A2 Boron-containing small molecules as anti-inflammatory agents
05/26/2010EP2187892A1 Method and means for the treatment of cachexia
05/26/2010EP2187891A1 Epimerization of 4'-c bond and modification of 14-ch3-(co)-fragment in anthracyclin antibiotics
05/26/2010EP2187890A1 Method for reducing intracranial pressure
05/26/2010EP2187889A2 Use of purine derivatives for the manufacture of a medicament
05/26/2010EP2187888A2 Bicyclic amides for enhancing glutamatergic synaptic responses
05/26/2010EP2187887A1 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
05/26/2010EP2187886A1 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
05/26/2010EP2187885A1 Dentifrice compositions for treating xerostomia
05/26/2010EP2187884A2 Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
05/26/2010EP2187883A2 Nitrogen containing bicyclic chemical entities for treating viral infections
05/26/2010EP2187882A1 Treatment of progressive neurodegenerative disease with ibudilast
05/26/2010EP2187881A1 Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue
05/26/2010EP2187880A1 Compositions and methods for treating macular degeneration
05/26/2010EP2187878A2 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
05/26/2010EP2187872A1 Extended release compositions comprising mycophenolate sodium and processes thereof
05/26/2010EP2187866A2 Dexamethasone formulations in a biodegradable material
05/26/2010EP2187746A1 Preparation of novel 1,3-substituted ureas as inhibitors of soluble epoxide hydrolase
05/26/2010EP2187743A2 Formulations for treatment of ocular diseases or conditions
05/26/2010EP2187742A1 Benzylbenzene derivatives and methods of use
05/26/2010EP2079724B1 Substituted pyridone compounds and methods of use
05/26/2010EP2029606B1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
05/26/2010EP1951730B1 Heteroalkyl linked pyrimidine derivatives
05/26/2010EP1948650B1 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives useful in treatment of trpv1 related disorders
05/26/2010EP1896470B1 Pyrrolopyridine derivatives as protein kinase inhibitors
05/26/2010EP1874783B1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
05/26/2010EP1874739B1 Pharmaceutically active diazepanes
05/26/2010EP1861400B1 Crystal forms of an imidazole derivative
05/26/2010EP1844048B1 Pyrazolopyrimidines as cell cycle kinase inhibitors
05/26/2010EP1730103B1 Formamide derivatives useful as adrenoceptor
05/26/2010EP1685135B1 TETRAHYDRO-FURO[3,4-d]DIOXOLE COMPOUNDS AND COMPOSITIONS AND METHOD FOR INHIBITING PLATELET AGGREGATION
05/26/2010EP1682483B1 Process for the preparation of polymorphs of sertraline hydrochloride
05/26/2010EP1651639B1 Benzofuran derivatives and their use in the treatment of microbial infections
05/26/2010EP1651613B1 4,5-dihydro-imidazole as p2x7 ion channel blockers
05/26/2010EP1622881B1 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect
05/26/2010EP1603915B1 SUBSTITUTED 8 -PYRIDINYL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE AND 8 -PYRIMIDIN YL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE DERIVATIVES AND THEIR USE AGAINST NEUROGENERATIVE DISEASES
05/26/2010EP1585727B1 Indoles useful in the treatment of androgen-receptor related diseases
05/26/2010EP1578426B1 Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia
05/26/2010EP1575379B1 Nutritional compositions
05/26/2010EP1562946B1 Novel xanthine derivatives, the production and the use thereof in the form of drugs
05/26/2010EP1539137B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
05/26/2010EP1537113B9 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
1 ... 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 ... 7860